Cigna Q1 2026 net income rises to $1.7 billion; 2026 outlook raised to $30.35 per share
The Cigna Group reported first quarter 2026 results on April 30, 2026, with total revenues up 5% to $68.5 billion and shareholders' net income of $1.7 billion, or $6.26 per share, versus $1.3 billion, or $4.85 per share, a year earlier. It raised its full-year 2026 adjusted income from operations outlook to at least $30.35 per share, up $0.10, which points to higher expected per-share earnings for shareholders. Within Evernorth, Pharmacy Benefit Services adjusted pre-tax income fell 28%, while Cigna Healthcare adjusted pre-tax income rose 18%.
Key points
- Total revenues rose 5% to $68.5 billion for the quarter ended March 31, 2026.
- Shareholders' net income was $1.7 billion, or $6.26 per share, versus $1.3 billion, or $4.85 per share, in Q1 2025.
- Adjusted income from operations was $2.1 billion, or $7.79 per share, versus $6.74 per share in Q1 2025.
- 2026 adjusted income from operations outlook is at least $30.35 per share, a $0.10 increase; Pharmacy Benefit Services adjusted pre-tax income fell 28%.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:21 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 30, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.